VitaLink Research (VLR) has acquired West Palm Beach, FL-based Comprehensive Clinical Trials (CCT). CCT focuses on providing Phase II – IV clinical trials with a therapeutic focus in women’s health. The addition of CCT enables VitaLink Research to provide high-quality clinical research to a greater number of patients throughout the Southeast.
“The partnership with Comprehensive Clinical Trials is a critical milestone in the company’s expansion into the growing field of women’s health,” said Nick Wright, CEO of VitaLink Research. “The addition of CCT enables us to partner with the fantastic team that Dr. Ackerman has built throughout his distinguished career as a physician and Principal Investigator. Additionally, I look forward to working with Dr. Ackerman to strategically grow our women’s health clinical research capabilities in existing VitaLink Research sites to increase the number of patients who can participate in these important research studies. Dr. Ackerman’s expertise in clinical research is world renowned and he will continue to lead the CCT business.”
“I am excited to partner with the entire VitaLink Research team to further grow our combined business over the coming years,” said Dr. Ronald Ackerman, Founder of CCT. “The strong infrastructure that VitaLink has established will enable CCT to focus exclusively on clinical research and expanding our women’s health expertise throughout the VitaLink network.”
VTL is owned by the health care investment firm, Great Point Partners (GPP), based in Greenwich, CT. The company has approximately $1bn of equity capital under management.